Foreign Experts Advisory Committee
Agustin Lage
Gender : Male
Email : lage@cim.sld.cu
Nationality : Cuba
University :
Employer : Center of Molecular Immunology
Current Location : Out of China
Introduction :

Dr. Agustin Lage is currently the General Director of the Center of Molecular Immunology (CIM) in Havana, Cuba. CIM is a research and manufacturing organization with a 1000 people staff, devoted to scientific research on cancer immunotherapy and to industrial manufacturing of monoclonal antibodies and therapeutic vaccines.CIM is also the Cuban partenr in a joint-venture company in China, named Biotech Pharmaceutical Ltd (BPL)located in Beijing and also devoted to research and production of therapeutic antibodies and vaccines. Dr.Lage is also member of the Board of Directors at BPL. Graduated in Medicine in the University of Havana in 1972, he completed specialization in Biochemistry and made post-grade studies in Pasteur Institut in France. After getting his PhD in Oncology in 1979 in Cuba, he was head of the Biochemistry Dpt at the National Institut of Oncology of Havana (INOR) and later (1985-1990) Deputy Director for Research at INOR. In 1991 he became Director General of the Center of Molecular Immunology in Havana. Research activities concentrated first in membrane changes associated with malignant transformation, and hormone receptors in breast cancer. Research focus moved then to monoclonal antibodies and cancer vaccines. He has published more than 150 scientific papers in specialized journals. Dr Lage is Merit Member of the Cuban Academy of Sciences, and Professor at the Faculty of Biology in Havana University. In 2009 he received the International Science and Technology Cooperation Award granted by the Council of State of the People´s Republic of China. Dr. Lage is a member of the Cuban Parliament (National Assambly).

Interest :

To introduce into the market novel biopharmaceuticals for cancer treatment - To develop new platform technologies for scale-up mammalian cell cultures - To organize a scientific collaborating networking on Molecular Immunology - To promote health care programs to evaluate the use of biopharmaceuticals in cancer patient management.

Send Private Message
: ()
: Agustin Lage (lage@cim.sld.cu)
:
Tel : 8610-68948899 ext 50418 Email : fepp@safea.gov.cn Address : No.5 Building, No.1 South Zhongguancun Street